36.6 F
New York
Thursday, April 22, 2021

Inovio Inc. [NASDAQ: INO] COVID-19 Vaccine Candidate Shows Promising Result

Must read

Palantir [NYSE: PLTR] Recognized as a Crown Commercial Service supplier

Palantir Technologies Inc. has gained recognition as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework. This award...

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Shares of Trevena, Inc. skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated...

InfuSystem Announces Acquisition of OB Healthcare Corporation

InfuSystem Holdings Inc. disclosed Wednesday that it has bought OB Healthcare Corporation. As per the acquisition agreement, the firm has purchased the operating...

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

Inovio Pharmaceuticals, Inc. [NASDAQ: INO] revealed today that its COVID-19 vaccine candidate has shown a positive result. INO-4800, a COVID-19 DNA vaccine candidate has proven to be useful as it has protected the non-human primates from live virus under the challenge of 13 weeks from last vaccination.

During the trial, INO-4800 decreased the viral infection in both the lower lungs and nasal passages in macaques that received two doses of INO-4800 four weeks apart. Then 13 weeks after the second dose, they encountered with live virus.

As the viral load decreased during this timeframe highlight an important durable effect mediated by INO-4800. This is the first time a vaccine candidate showed positive results in protecting non-human primates.

Inovio’s shares have closed green during the trading of Thursday and exhibited a change of 12.65% and up +21.95. It has previously opened at $21.10 and closed at $21.95.

Inovio had a trading volume of 16.94 million as compared to the average volume of 36.57 million. In the past 52-weeks of trading, this company’s stocks have changed between the low of $1.91 and a high of $33.79.

If we look at its profitability, its return on assets (ROA) is -61.40%, return on investment (ROI) is -137.90%, and return on equity (ROE) of -178.40%. Turning our focus on liquidity, its current ratio and quick ratio is 8.50. Inovio has a total market capitalization of 3.45 billion.

INO-4800 which is a DNA vaccine candidate of INOVIO is created to protect against COVID-19. This candidate is currently in the Phase 1 trial and expected to start the phase 2/3 trial in the Summer.

INO-4800’s protective results were mediated by memory T and B cell immune responses from INO-4800 vaccination. B cells are involved in the production of antibodies which recognized SARS-CoV-2 while the T cells are involved in the destruction of viral cell and also aid B cell response.

Immunization with INO-4800 has the ability to decrease the active viral replication and has the ability to reduce the severity of the infection.

More articles

Latest article

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...